ReviewJournal of clinical medicine2022
PARP Inhibitors as Monotherapy in Daily Practice for Advanced Prostate Cancers.
Diego Teyssonneau et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ReviewJournal of clinical medicine2022
Diego Teyssonneau et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.